Literature DB >> 25982705

Psychosexual therapy and education in patients treated for cancer of the head and neck.

J Hoole1, A N Kanatas2, D A Mitchell3.   

Abstract

It is now widely accepted that cancer is a chronic disease, and in this context we have previously highlighted shortcomings in the assessment of problems with intimacy and sexuality in patients treated for cancer of the head and neck. In this paper we introduce established strategies for the diagnosis and treatment of psychosexual problems to support these patients, and describe our early experiences of their use. We include brief narratives and case reports to show how they have made a difference to patients and their partners.
Copyright © 2015 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Head and neck cancer; Health-related quality of life; Intimacy; Oral cancer; Psychosexual therapy; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 25982705     DOI: 10.1016/j.bjoms.2015.04.022

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Priorities and Preferences of Patients With Head and Neck Cancer for Discussing and Receiving Information About Sexuality and Perception of Self-Report Measures.

Authors:  Bethany A Rhoten; Amanda J Davis; Breanna N Baraff; Kelly H Holler; Mary S Dietrich
Journal:  J Sex Med       Date:  2020-05-13       Impact factor: 3.802

Review 2.  Head and neck cancer survivorship consensus statement from the American Head and Neck Society.

Authors:  Neerav Goyal; Andrew Day; Joel Epstein; Joseph Goodman; Evan Graboyes; Scharukh Jalisi; Ana P Kiess; Jamie A Ku; Matthew C Miller; Aru Panwar; Vijay A Patel; Assuntina Sacco; Vlad Sandulache; Amy M Williams; Daniel Deschler; D Gregory Farwell; Cherie-Ann Nathan; Carole Fakhry; Nishant Agrawal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.